X

Trial Profile

Randomized Phase II Trial of Post-operative Adjuvant Chemotherapy +/- FANG Autologous Tumor Cell Vaccine in Colorectal Carcinoma With Liver Metastases.

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 02 Jul 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bi-shRNAfurin-GM-CSF-loaded tumour cell vaccine (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
Indications Colorectal cancer; Liver metastases
Focus Pharmacodynamics; Therapeutic Use
Acronyms FANG-CLM
Sponsors Gradalis

Most Recent Events

21 May 2018 Status changed from completed to discontinued.
23 Feb 2017 Status changed from active, no longer recruiting to completed.
06 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com